isomethyleugenol has been researched along with maytansine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, L; Carroll, B; Floss, HG; Kang, Q; Shang, G; Spiteller, P; Su, W; Wu, Y; Yu, TW | 1 |
| Bumbaca, D; Girish, S; Khojasteh, SC; Saad, O; Shen, BQ; Tibbitts, J; Yue, Q | 1 |
2 other study(ies) available for isomethyleugenol and maytansine
| Article | Year |
|---|---|
N-methylation of the amide bond by methyltransferase asm10 in ansamitocin biosynthesis.
Topics: Actinomycetales; Amides; Lactams, Macrocyclic; Maytansine; Methylation; Methyltransferases | 2011 |
Non-Clinical Disposition and Metabolism of DM1, a Component of Trastuzumab Emtansine (T-DM1), in Sprague Dawley Rats.
Topics: Ado-Trastuzumab Emtansine; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bile; Biotransformation; Feces; Female; Glutathione; Hepatobiliary Elimination; Hydrolysis; Injections, Intravenous; Liver; Maytansine; Methylation; Molecular Structure; Oxidation-Reduction; Rats, Sprague-Dawley; Renal Elimination; Tissue Distribution; Trastuzumab | 2015 |